Assessing anti-emetics and nausea
Using a suite of man rated motion devices and a validated model we assess potential anti-emetic/anti-nausea compounds in terms of their efficacy and tolerability. These trials are key to mitigating the debilitating side effects of chemotherapy and other treatments.
We can provide
- A proven model of nausea
- Effective assessment of drug efficacy and tolerability
- Statistical analysis and comparative interpretation
- Customised drug testing software covering pre-clinical and Phase I, II and III studies
- Specialist motion laboratory
For more information contact us or telephone +44 (0)8700 100942
- Contact us: by phone: +44 (0) 8700 100 942
- by
- post
- via our
- enquiry form
QinetiQ Group PLC, Company Registration No 4586941, Registered Office 85 Buckingham Gate, London SW1E 6PD